emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Cryo-Save Group (Now Esperite) / Life RF doo (now Cryo-Save Serbia Beograd)

No EMAT : 71398
Announced Date : 03/02/2011
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Cryo-Save Group (Now Esperite)

Target : Life RF doo (now Cryo-Save Serbia Beograd)
Country : Serbia
Sector of activity :
  • Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Laboratories
Business Description :
Life R.F. is a family stem cell bank. > Strong network amongst Serbia's gynaecologists. > Has been a distributor for Cryo-Save for many years.

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current ns ns ns ns
Rating : **
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Laboratories » = 130
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
30/04/2013 Source Bioscience Inverclyde Biologicals England *** 71359
07/07/2014 IDCSalud Holding SL (Formerly Capio) Grupo Hospitalario Quirón Spain * 71222

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report